Baman JR, Eskandari MK. What is an abdominal aortic aneurysm? JAMA. 2022;328:2280.
Anagnostakos J, Lal BK. Abdominal aortic aneurysms. Prog Cardiovasc Dis. 2021;65:34–43.
Golledge J. Abdominal aortic aneurysm: update on pathogenesis and medical treatments. Nat Rev Cardiol. 2019;16:225–42.
Nugroho NT, Herten M, Torsello GF, Osada N, Marchiori E, Sielker S, Torsello GB. Association of genetic polymorphisms with abdominal aortic aneurysm in the processes of apoptosis, inflammation, and cholesterol metabolism. Medicina. 2023;59(10):1844. https://doi.org/10.3390/medicina59101844.
Article PubMed PubMed Central Google Scholar
Dong H, Zhang Y, Huang Y, Deng H. Pathophysiology of RAGE in inflammatory diseases. Front Immunol. 2022;13: 931473.
Article CAS PubMed PubMed Central Google Scholar
Tobon-Velasco JC, Cuevas E, Torres-Ramos MA. Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress. CNS Neurol Disord Drug Targets. 2014;13:1615–26.
Article CAS PubMed Google Scholar
Xie J, Mendez JD, Mendez-Valenzuela V, Aguilar-Hernandez MM. Cellular signalling of the receptor for advanced glycation end products (RAGE). Cell Signal. 2013;25:2185–97.
Article CAS PubMed Google Scholar
Hudson BI, Lippman ME. Targeting RAGE signaling in inflammatory disease. Annu Rev Med. 2018;69:349–64.
Article CAS PubMed Google Scholar
Park S, Yoon SJ, Tae HJ, Shim CY. RAGE and cardiovascular disease. Front Biosci (Landmark Ed). 2011;16:486–97.
Article CAS PubMed Google Scholar
Fujita T. AGE/RAGE axis in the development of abdominal aortic aneurysm. Ann Surg. 2010;252:203–5.
Zhang F, Kent KC, Yamanouchi D, Zhang Y, Kato K, Tsai S, et al. Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm. Ann Surg. 2009;250:416–23.
Li Y, Zheng X, Guo J, Samura M, Ge Y, Zhao S, et al. Treatment with small molecule inhibitors of advanced glycation end-products formation and advanced glycation end-products-mediated collagen cross-linking promotes experimental aortic aneurysm progression in diabetic mice. J Am Heart Assoc. 2023;12: e028081.
Article CAS PubMed PubMed Central Google Scholar
Renfeng Q, Shuxiao C, Peixian G, Kun L, Xuedong F, Hai Y et al. ADAM10 attenuates the development of abdominal aortic aneurysms in a mouse model. Mol Med Rep, 2021; 24
Morgan S, Yamanouchi D, Harberg C, Wang Q, Keller M, Si Y, et al. Elevated protein kinase C-delta contributes to aneurysm pathogenesis through stimulation of apoptosis and inflammatory signaling. Arterioscler Thromb Vasc Biol. 2012;32:2493–502.
Article CAS PubMed Google Scholar
Tian K, Xia C, Liu H, Xu B, Wei P, Fu W, et al. Temporal and quantitative analysis of aortic immunopathologies in elastase-induced mouse abdominal aortic aneurysms. J Immunol Res. 2021;2021:6297332.
Article PubMed PubMed Central Google Scholar
Raffort J, Lareyre F, Clement M, Hassen-Khodja R, Chinetti G, Mallat Z. Monocytes and macrophages in abdominal aortic aneurysm. Nat Rev Cardiol. 2017;14:457–71.
Song H, Yang Y, Sun Y, Wei G, Zheng H, Chen Y, et al. Circular RNA Cdyl promotes abdominal aortic aneurysm formation by inducing M1 macrophage polarization and M1-type inflammation. Mol Ther. 2022;30:915–31.
Article CAS PubMed Google Scholar
Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest. 2002;110:625–32.
Article CAS PubMed PubMed Central Google Scholar
Feng X, Zhu S, Qiao J, Ji Z, Zhou B, Xu W. CX3CL1 promotes M1 macrophage polarization and osteoclast differentiation through NF-kappaB signaling pathway in ankylosing spondylitis in vitro. J Transl Med. 2023;21:573.
Article CAS PubMed PubMed Central Google Scholar
Wang S, Lu M, Wang W, Yu S, Yu R, Cai C, et al. Macrophage polarization modulated by NF-kappaB in polylactide membranes-treated peritendinous adhesion. Small. 2022;18: e2104112.
Li Y, Tao L, Xu Y, Guo R. Taxifolin ameliorates abdominal aortic aneurysm by preventing inflammation and apoptosis and extracellular matrix degradation via inactivating TLR4/NF-kappaB axis. Int Immunopharmacol. 2023;119: 110197.
Article CAS PubMed Google Scholar
Shi J, Guo J, Li Z, Xu B, Miyata M. Importance of NLRP3 inflammasome in abdominal aortic aneurysms. J Atheroscler Thromb. 2021;28:454–66.
Article CAS PubMed PubMed Central Google Scholar
Pickering RJ, Tikellis C, Rosado CJ, Tsorotes D, Dimitropoulos A, Smith M, et al. Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis. J Clin Invest. 2019;129:406–21.
Senatus L, Lopez-Diez R, Egana-Gorrono L, Liu J, Hu J, Daffu G, et al. RAGE impairs murine diabetic atherosclerosis regression and implicates IRF7 in macrophage inflammation and cholesterol metabolism. JCI Insight, 2020; 5
Mocanu CA, Fuior EV, Voicu G, Rebleanu D, Safciuc F, Deleanu M, et al. P-selectin targeted RAGE-shRNA lipoplexes alleviate atherosclerosis-associated inflammation. J Control Release. 2021;338:754–72.
Article CAS PubMed Google Scholar
Jeong J, Lee J, Lim J, Cho S, An S, Lee M, et al. Soluble RAGE attenuates AngII-induced endothelial hyperpermeability by disrupting HMGB1-mediated crosstalk between AT1R and RAGE. Exp Mol Med. 2019;51:1–15.
Article CAS PubMed Google Scholar
Singh S, Siva BV, Ravichandiran V. Advanced glycation end products: key player of the pathogenesis of atherosclerosis. Glycoconj J. 2022;39:547–63.
Article CAS PubMed Google Scholar
Mi L, Zhang Y, Xu Y, Zheng X, Zhang X, Wang Z, et al. HMGB1/RAGE pro-inflammatory axis promotes vascular endothelial cell apoptosis in limb ischemia/reperfusion injury. Biomed Pharmacother. 2019;116: 109005.
Article CAS PubMed Google Scholar
Li Z, Fu WJ, Chen XQ, Wang S, Deng RS, Tang XP, et al. Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization. J Exp Clin Cancer Res. 2022;41:74.
Article CAS PubMed PubMed Central Google Scholar
Wang J, Li R, Peng Z, Hu B, Rao X, Li J. HMGB1 participates in LPS-induced acute lung injury by activating the AIM2 inflammasome in macrophages and inducing polarization of M1 macrophages via TLR2, TLR4, and RAGE/NF-kappaB signaling pathways. Int J Mol Med. 2020;45:61–80.
Choi J, Oh S, Son M, Byun K. Pyrogallol-Phloroglucinol-6,6-Bieckol Alleviates Obesity and Systemic Inflammation in a Mouse Model by Reducing Expression of RAGE and RAGE Ligands. Mar Drugs, 2019; 17
Jahan H, Choudhary MI. Gliclazide alters macrophages polarization state in diabetic atherosclerosis in vitro via blocking AGE-RAGE/TLR4-reactive oxygen species-activated NF-kbeta nexus. Eur J Pharmacol. 2021;894: 173874.
Article CAS PubMed Google Scholar
Oh H, Park SH, Kang MK, Kim YH, Lee EJ, Kim DY, et al. Asaronic acid attenuates macrophage activation toward M1 phenotype through inhibition of NF-kappaB pathway and JAK-STAT signaling in glucose-loaded murine macrophages. J Agric Food Chem. 2019;67:10069–78.
Article CAS PubMed Google Scholar
Liu Z, Ma Y, Cui Q, Xu J, Tang Z, Wang Y, et al. Toll-like receptor 4 plays a key role in advanced glycation end products-induced M1 macrophage polarization. Biochem Biophys Res Commun. 2020;531:602–8.
Comments (0)